These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan. Miyamoto S; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Minematsu K; Murakawa Y; Iwashiro S; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104584. PubMed ID: 31983518 [TBL] [Abstract][Full Text] [Related]
32. An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs. Deedwania P; Huang GW Rev Cardiovasc Med; 2012; 13(2-3):e89-104. PubMed ID: 23160166 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of perioperative dual antiplatelet therapy with ticagrelor versus clopidogrel in carotid artery stenting. Marcaccio CL; Patel PB; Liang P; Rastogi V; Stangenberg L; Jim J; Schneider PA; Schermerhorn ML J Vasc Surg; 2022 Apr; 75(4):1293-1303.e8. PubMed ID: 34655685 [TBL] [Abstract][Full Text] [Related]
34. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy. Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955 [TBL] [Abstract][Full Text] [Related]
36. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study. Buller HR; Halperin J; Hankey GJ; Pillion G; Prins MH; Raskob GE J Thromb Haemost; 2014 Jun; 12(6):824-30. PubMed ID: 24597472 [TBL] [Abstract][Full Text] [Related]
37. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation. Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T; Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700 [TBL] [Abstract][Full Text] [Related]
38. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525 [TBL] [Abstract][Full Text] [Related]
39. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538 [TBL] [Abstract][Full Text] [Related]
40. Choice of antithrombotic therapy for patients with atrial fibrillation undergoing carotid angioplasty and stenting: a nationwide population-based study. Huang YC; Huang YC; Cheng YC; Chen M Sci Rep; 2022 Jan; 12(1):1417. PubMed ID: 35082380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]